Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 OMS302 in high-risk IFIS patients undergoing intraocular lens replacement
2013-003885-15Phase 3Terminated
- Sponsor
- Omeros Corporation
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intraoperative floppy iris syndrome (IFIS) comparing OMS302 with Placebo (2 arms). Started Oct 2013; status: terminated.
02
Drugs
phenylephrine + ketorolac
03
Conditions
intraoperative floppy iris syndrome (IFIS)
Beyond the preview
Go deeper on 2013-003885-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003885-15.